The involvement of CNTF in human body metabolism has serendipitously been discovered in clinical trials evaluating its efficacy in ALS patients; although administration of human recombinant CNTF did not ameliorate their motor symptoms, it unexpectedly induced weight loss23,24. This evidence concerns the gene CNTF and amyotrophic lateral sclerosis.